Table 2.
Studies assessing the improvement of symptoms and the quality of life of symptomatic women.
| Author and Year of Publication | Patient Follow-up Time | Number of Patients | Mean Age and Standard Deviation | Mean Reduction in SSS | Increase in the Overall UFS-QOL Score | Symptom Improvement | NPV Mean (%) |
|---|---|---|---|---|---|---|---|
| Park et al., 2014 | 3 months | 79 | 43.6±4.4 | 35.6% | - | SIM | 62.7±25.5 |
| Park et al., 2012** | 3 months | 9 | 39.8±6.2 | 55.5% | - | SIM | 66.9±10.6 |
| Kim et al., 2012 | 3 months | 27 | 44.5±3.8 | 35.8 | - | SIM | 64.2±19.9 |
| Harding et al., 2008 | 6 months | 102 | 45±4.8 | 44.8% | 33.6% | SIM | - |
| Ikink et al., 2013 | 6 months | 46 | 45.3±4.1 | 31.8% | 19.5% | SIM | 40±22 |
| Mikami et al., 2008 | 6 months | 48 | 45±5.2 | - | - | SIM | 47±13 |
| Hindley et al., 2004 | 6 months | 109 | 44.8±4.9 | - | - | SIM | 25±6.0 |
| Lenard et al., 2008 | 12 months | 66 | 45.4±4.4 | 38.8% | - | SIM | 16.3±13.3 |
| Dobrotwir et al., 2012 | 12 months | 74 | 42±7.0 | 51% | - | SIM | 67±25 |
| Gorny et al., 2011 | 12 months | 130 | 45.6±5.5 | - | - | SIM | 45.4±22.5 |
| Stewart et al., 2006* | 12 months | 109 | 44.8±4.9 | 51% | - | SIM | - |
| Funaki et al., 2009 | 24 months | 91 | 40.4±4.6 | 65.5% | - | SIM | 67±25 |
| Wang et al., 2012 | 24 months | 78 | 38.2±6.4 | - | 31.25% | SIM | 80±12 |
| Stewart et al., 2007 | 24 months | 359 | 45.4±5.0 | 35.6% | - | SIM | 19.9±17.2/21.9±18.7 |
| Mindjuk et al., 2014 | 24 months | 252 | 42.1±6.9 | 70% | - | SIM | 88.7±14.4 |
| Kim et al., 2011 | 36 months | 40 | 45.98±4.52 | 73.7% | 47.4% | SIM | 32.1±6.2 |
SSS: Symptom Severity Score.
*
Clinical Trial.
**
Study of women with pedunculated subserosal fibroids.